Zdrowie i gospodarka · 25/02/2004
FDA Announces Availability of Draft Guidance for Vascular and Neurovascular Embolization Devices
The FDA is releasing a draft guidance document to support the reclassification of vascular and neurovascular embolization devices from class III to class II, and withdrawing a 1994 draft guidance on biocompatibility requirements for neurological implants.
Source: Federal Register — Food and Drug AdministrationOpen original release →